Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

SU-101 advances to phase III for relapsed glioblastoma

Jan. 16, 1998

Gliadel Wafer enters additional phase III study

Jan. 16, 1998

Onyx and Warner-Lambert renew cell cycle regulation agreement

Jan. 16, 1998

Cancer gene therapy technology available for licensing from NIH

Jan. 16, 1998

Novel tumor vaccine technology described by U.S. researchers

Jan. 15, 1998

Pacific receives patent allowance for immune system stimulant

Jan. 15, 1998

New proto-oncogene inhibitor isolated from fungus by Schering-Plough

Jan. 15, 1998

Pharma Mar discovers new antitumor heptapeptide from Australian ascidian

Jan. 15, 1998

Indian researchers describe new anticancer agent

Jan. 14, 1998

Korean researchers discover new PLC and PI turnover inhibitor from fungal strain

Jan. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...